[Form 3] Albemarle Corporation Initial Statement of Beneficial Ownership
Rhea-AI Filing Summary
Krupa Ander C., General Counsel & Secretary of Albemarle Corporation, reported beneficial ownership of 4,341 common shares, consisting of 1,560 issued shares and 2,781 restricted stock units granted across 2023–2025 with staggered vesting through 2028. She also disclosed 2,676 stock options: 1,608 exercisable 02/27/2028 (exp. 02/26/2035) at $78.97 and 1,068 exercisable 02/22/2027 (exp. 02/21/2034) at $118.18. All holdings and vesting terms are reported on Form 3.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider Form 3 reports 4,341 shares and 2,676 options; disclosure is informational and not a material corporate event.
The filing provides clear, itemized disclosure of current equity holdings for Krupa Ander C., including the exact split between issued shares and RSUs and full option schedules with exercise prices and expiration dates. This is a standard Section 16 filing that notifies the market of insider holdings rather than indicating a transaction or change in control. The specific numbers and vesting/exercise timelines are useful for monitoring future potential insider exercises or vesting-related sales.
TL;DR: Form 3 documents officer equity exposure and multi-year RSU vesting; relevant for compliance and disclosure records.
The report lists detailed equity compensation components: 2,781 RSUs with discrete vesting dates (2026, 2027, 2028) and 2,676 options with specified exercisable dates, prices, and expirations. For governance and compliance teams, these explicit vesting and option schedules help track insider lockup windows and potential future reportable transactions. The filing is descriptive and aligned with routine reporting obligations.